Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00664261 · ClinicalTrials.gov registry record · NA
Clinical Effort Against Secondhand Smoke (CEASE) Program or Standard Care in Helping Parents Stop Smoking
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 3,000
- Enrollment target
NCT00664261: Completed NA study, sponsored by Massachusetts General Hospital.
NCT00664261 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 3,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00664261, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,000 participants
- Enrollment target
Study Summary
RATIONALE: The Clinical Effort Against Secondhand Smoke (CEASE) program may be more effective than standard care in increasing the number of parents who stop smoking. PURPOSE: This randomized clinical trial is studying how well the CEASE program works compared with standard care in helping parents stop smoking.
Interventions
- OTHER laboratory biomarker analysis
- OTHER educational intervention
- OTHER counseling intervention
- BEHAVIORAL smoking cessation intervention
- OTHER cancer prevention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2007-09 |
| Est. Completion | 2013-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00664261
The ClinicalTrials.gov registry entry for NCT00664261 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which laboratory biomarker analysis is the first listed.
NCT00664261 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00664261 about?
NCT00664261 is a clinical study titled "Clinical Effort Against Secondhand Smoke (CEASE) Program or Standard Care in Helping Parents Stop Smoking". RATIONALE: The Clinical Effort Against Secondhand Smoke (CEASE) program may be more effective than standard care in increasing the number of parents who stop smoking. PURPOSE: This randomized clinical trial is studying how well the CEASE program works compared with standard care in helping parents ...
What is the current status of trial NCT00664261?
This trial is currently completed. It is a NA study. The enrollment target is 3,000 participants. The study started on 2007-09. Estimated completion is 2013-07.
What interventions are being tested in trial NCT00664261?
The interventions under investigation include: laboratory biomarker analysis (OTHER), educational intervention (OTHER), counseling intervention (OTHER), smoking cessation intervention (BEHAVIORAL), cancer prevention (OTHER).
Who is sponsoring clinical trial NCT00664261?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.